Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
The company will soon be launching a new portfolio of products in this segment
Consolidated revenue from operations stood at Rs. 111.05 crore
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
Gelhaus has a proven track record of driving business growth
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Subscribe To Our Newsletter & Stay Updated